Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Gröner

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Endocrine|January 2, 2019
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseasesChristian Happel, Wolfgang Tilman Kranert, Hanns Ackermann, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease: preparation, feasibility and efficiency - preliminary resultsAlexander Mader, Oscar Maximilian Mader, Daniel Gröner, et al.
Thyroid : Official Journal of the American Thyroid Association|April 30, 2014
Evaluation of fear of radiation and isolation before and after radioiodine therapyFriederike von Müller, Christian Happel, Jörg Reinhardt, et al.
Seminars in Nuclear Medicine|October 16, 2025
Recent Advances and Future Trends of[<sup>18</sup>F]-Labeled PET Agents for Renal ImagingTakahiro Higuchi, Xinyu Chen, Sophie C Siegmund, et al.
European Journal of Radiology|October 26, 2016
Cooled microwave ablation of thyroid nodules: Initial experienceYücel Korkusuz, Oscar Maximilian Mader, Wolfgang Kromen, et al.
Nuklearmedizin. Nuclear Medicine|February 16, 2022
[Anticipating Criteria for Discharge after Lu-177-PSMA Treatment - Discussion of Several Scenarios]Wolfgang Tilman Kranert, Benjamin Bockisch, Jennifer Wichert, et al.
JCO Precision Oncology|December 6, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With <i>BRCA</i> Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand TherapyMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Cell Death & Disease|October 6, 2017
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1Li Liu, Ewa Aleksandrowicz, Frank Schönsiegel, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Endocrine|January 2, 2019
Thyroid stunning in radioiodine-131 therapy of benign thyroid diseasesChristian Happel, Wolfgang Tilman Kranert, Hanns Ackermann, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Minimally invasive local ablative therapies in combination with radioiodine therapy in benign thyroid disease: preparation, feasibility and efficiency - preliminary resultsAlexander Mader, Oscar Maximilian Mader, Daniel Gröner, et al.
Thyroid : Official Journal of the American Thyroid Association|April 30, 2014
Evaluation of fear of radiation and isolation before and after radioiodine therapyFriederike von Müller, Christian Happel, Jörg Reinhardt, et al.
Seminars in Nuclear Medicine|October 16, 2025
Recent Advances and Future Trends of[<sup>18</sup>F]-Labeled PET Agents for Renal ImagingTakahiro Higuchi, Xinyu Chen, Sophie C Siegmund, et al.
European Journal of Radiology|October 26, 2016
Cooled microwave ablation of thyroid nodules: Initial experienceYücel Korkusuz, Oscar Maximilian Mader, Wolfgang Kromen, et al.
Nuklearmedizin. Nuclear Medicine|February 16, 2022
[Anticipating Criteria for Discharge after Lu-177-PSMA Treatment - Discussion of Several Scenarios]Wolfgang Tilman Kranert, Benjamin Bockisch, Jennifer Wichert, et al.
JCO Precision Oncology|December 6, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With <i>BRCA</i> Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand TherapyMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Cell Death & Disease|October 6, 2017
Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1Li Liu, Ewa Aleksandrowicz, Frank Schönsiegel, et al.
Pageof 2